RO-7119929

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRO-7119929
Drug Alias NameRO-7119929RG-6115
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsLiver NeoplasmsBiliary Tract NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanDenmark +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsBiliary Tract NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A